ATE135015T1 - Vasodilatierende und immunsupprimierende peptide - Google Patents
Vasodilatierende und immunsupprimierende peptideInfo
- Publication number
- ATE135015T1 ATE135015T1 AT90911134T AT90911134T ATE135015T1 AT E135015 T1 ATE135015 T1 AT E135015T1 AT 90911134 T AT90911134 T AT 90911134T AT 90911134 T AT90911134 T AT 90911134T AT E135015 T1 ATE135015 T1 AT E135015T1
- Authority
- AT
- Austria
- Prior art keywords
- proteins
- immunosumptimizing
- vasodilating
- peptides
- mammal
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000000304 vasodilatating effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 3
- 102100038518 Calcitonin Human genes 0.000 abstract 2
- 108060001064 Calcitonin Proteins 0.000 abstract 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 abstract 1
- 241000255134 Lutzomyia <genus> Species 0.000 abstract 1
- 241000255634 Lutzomyia longipalpis Species 0.000 abstract 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
- 229960004015 calcitonin Drugs 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000004576 sand Substances 0.000 abstract 1
- 230000024883 vasodilation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37408089A | 1989-06-29 | 1989-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE135015T1 true ATE135015T1 (de) | 1996-03-15 |
Family
ID=23475190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90911134T ATE135015T1 (de) | 1989-06-29 | 1990-06-29 | Vasodilatierende und immunsupprimierende peptide |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0479899B1 (de) |
| JP (1) | JPH06502385A (de) |
| AT (1) | ATE135015T1 (de) |
| AU (1) | AU5966490A (de) |
| CA (1) | CA2063260A1 (de) |
| DE (1) | DE69025763T2 (de) |
| WO (1) | WO1991000293A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5397772A (en) * | 1989-06-29 | 1995-03-14 | The President And Fellows Of Harvard College | Vasodilatory peptides from the salivary gland of the sand fly Lutzomyia longipalpis |
| US5294543A (en) * | 1992-04-08 | 1994-03-15 | The General Hospital Corporation | Inhibitor of platelet aggregation |
| CA2155866A1 (en) * | 1993-02-12 | 1994-08-18 | Jose M. C. Ribeiro | Method of enhancing hair growth and hair revitalizing compositions comprising lutzomyia protein |
| US5480864A (en) * | 1993-08-06 | 1996-01-02 | Shiseido Co., Ltd. | Modified maxadilan protein, its preparation and use, and DNA encoding the protein |
| KR100361933B1 (ko) | 1993-09-08 | 2003-02-14 | 라 졸라 파마슈티칼 컴파니 | 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트 |
| KR950007873A (ko) * | 1993-09-20 | 1995-04-15 | 후꾸하라 요시하루 | 생리 활성 물질 지속 방출형의 의약 제제 |
| US6462016B1 (en) | 1995-10-06 | 2002-10-08 | Shiseido Company, Ltd. | Method for screening agonist or antagonist of the maxadilan receptor participating in vasodilating action, and compound found by the method |
-
1990
- 1990-06-29 AT AT90911134T patent/ATE135015T1/de not_active IP Right Cessation
- 1990-06-29 CA CA002063260A patent/CA2063260A1/en not_active Abandoned
- 1990-06-29 DE DE69025763T patent/DE69025763T2/de not_active Expired - Fee Related
- 1990-06-29 AU AU59664/90A patent/AU5966490A/en not_active Abandoned
- 1990-06-29 JP JP2510163A patent/JPH06502385A/ja active Pending
- 1990-06-29 EP EP90911134A patent/EP0479899B1/de not_active Expired - Lifetime
- 1990-06-29 WO PCT/US1990/003746 patent/WO1991000293A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0479899B1 (de) | 1996-03-06 |
| WO1991000293A1 (en) | 1991-01-10 |
| CA2063260A1 (en) | 1990-12-30 |
| AU5966490A (en) | 1991-01-17 |
| JPH06502385A (ja) | 1994-03-17 |
| DE69025763T2 (de) | 1996-09-05 |
| EP0479899A1 (de) | 1992-04-15 |
| DE69025763D1 (de) | 1996-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK672788A (da) | Rekombinant-dna-vektorer til direkte udtrykkelse af aktiveret humant protein c | |
| DE3587958D1 (de) | Rekombinantes alveolares oberflächenaktives protein. | |
| RU95115239A (ru) | Аналог эритропоэтина | |
| DZ467A1 (fr) | Interferon immunitaire urbain. | |
| FI102379B1 (fi) | Uretaanisuojattuja aminohappo-N-karboksianhydridejä | |
| ATE114163T1 (de) | Exprimierung in säugetieren der bmp-2 familie. | |
| NO972264D0 (no) | Fremgangsmåter for behandling av multippel sklerose ved bruk av peptidanaloger av human myelin basis protein | |
| KR840005739A (ko) | 인체릴랙신(relaxin)을 암호하는 유전자의 분리방법 및 릴랙신 활성을 갖는 폴리펩티드의 제조방법 | |
| PT85977A (en) | Process for the preparation of human apolipoprotein ai and their variant forms by recombinant dna methods | |
| DE3685626D1 (de) | Sequenzierung von peptiden. | |
| DK447684A (da) | Homogent immuninterferon | |
| DK175843B1 (da) | Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet | |
| DK0975761T3 (da) | Humant, rekombinant beta-interferon med forbedret opløselighed | |
| NO169725C (no) | Fremgangsmaate for fremstilling av et uglykosylert rekombinant humant immun-interferonprotein | |
| DE69331501D1 (de) | Unterdrückung der Proliferation von T-Zellen mittels Peptidfragmenten des basischen Proteins aus Myelin | |
| ATE135015T1 (de) | Vasodilatierende und immunsupprimierende peptide | |
| FI891848A7 (fi) | Eristettyjen proteiinipitoisten aineiden valmistus käyttäen lintujen rekombinanttirokkovirusvektoreja | |
| IE870507L (en) | Bovine virus diarrhea and hog cholera vaccines | |
| ES2080060T3 (es) | Proteinas que tienen actividad de union a interferon-gamma. | |
| ES2009588A6 (es) | Un metodo para la preparacion de un polipeptido. | |
| DK2086A (da) | Protraheret virkende sterilt vandigt praeparat af et peptid eller protein, dets fremstilling og anvendelse | |
| DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
| DE69330348D1 (de) | Verwendung von Peptiden welche eine Immunantwort bewirken zur Herstellung von Medikamenten zur Induzierung der Immunsuppression. | |
| FI906112A7 (fi) | Menetelmiä ja koostumuksia nisäkkäiden infektioiden käsittelemiseksi k äyttämällä lääkkeitä, jotka käsittävät pistiäisten myrkkyä, sen protei ini- tai polypeptidiainesosia tai näiden porteiini- tai polypeptidiain eosien analogeja | |
| IL86699A0 (en) | Cell system for expression of recombinant protein without production of virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |